Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Patent CN107382874A details high-yield synthesis of chiral NHC salts. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel chiral N-heterocyclic carbene catalyst improves yield and dr value in asymmetric reactions, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN106046065B details a high-yield synthesis of chiral ferrocene ligands. Discover cost-effective manufacturing and reliable supply chain solutions for asymmetric catalysis.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN111471020B reveals a novel Rh-catalyzed route for Avapritinib intermediates, offering safer conditions and reduced costs for reliable API manufacturing.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN102382138B details a robust two-step synthesis for chiral phosphoramides. Discover cost-effective manufacturing routes for asymmetric catalysis intermediates.
Patent CN113135955B discloses a scalable route for C2 symmetric Trost ligands, offering cost reduction in asymmetric catalysis manufacturing and reliable supply.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Discover the novel chiral zinc-nitrogen complex from patent CN102887912A. Enhance asymmetric synthesis capabilities with our reliable supply of specialized catalytic intermediates.
Patent CN1968958A details a novel asymmetric copper complex method for high-purity cyclopropane intermediates, offering significant cost reduction in agrochemical manufacturing.
Patent CN115490732B discloses a novel one-pot synthesis for chiral biphenyl diol selenium sulfide catalysts offering mild conditions and cost-effective manufacturing for fine chemical intermediates.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.
Patent CN111018901A reveals a novel synthetic route for Zanamivir and Laninamivir intermediates, offering enhanced purity and cost-effective manufacturing solutions.
Patent CN101952242A details a novel convergent synthesis for renin inhibitors like aliskiren, offering improved stereocontrol and scalability for pharmaceutical manufacturers.